ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DSM invests in genetic test firm

November 13, 2006 | APPEARED IN VOLUME 84, ISSUE 46

DSM Venturing will make a $2.5 million equity investment in IntegraGen, which specializes in genetic tests for complex diseases. At the same time, DSM's personalized nutrition group is forming an R&D partnership with IntegraGen to develop molecular diagnostic products for personalized health care. Each company will retain rights to intellectual property in its area of focus: diagnostics and medicines for IntegraGen and nutrition for DSM.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment